Bcl-2

Apr 13, 2018

Tolero Pharmaceuticals to Present Preclinical Data Supporting Apoptosis-Inducing Activity of Alvocidib in Acute Myeloid Leukemia

Apr 12, 2018

Ascentage Pharma Announces Five Abstracts To Be Presented at the 2018 American Association for Cancer Research Annual Meeting

Jan 08, 2018

MEI Pharma Announces FDA Clearance of Investigational New Drug Application for CDK Inhibitor Voruciclib

Jan 05, 2018

Ascentage Pharma to Present at the 36th Annual J.P. Morgan Healthcare Conference

Dec 21, 2017

MEI Pharma Announces Study of Clinical Stage Oral CDK Inhibitor Voruciclib Published in Nature Scientific Reports

Nov 15, 2017

Ascentage Pharma Announces U.S. FDA Acceptance of IND Application for Clinical Study of Novel IAP Inhibitor APG-1387 to Treat Advanced Solid Tumors and Blood Cancers

Sep 18, 2017

AbbVie Announces Positive Topline Results from Phase 3 Trial Evaluating VENCLEXTA(TM)/VENCLYXTO(TM) (Venetoclax) Tablets in Combination with Rituxan® (rituximab) for the Treatment of Patients with Relapsed/Refractory Chronic Lymphocytic Leukemia

Sep 05, 2017

MEI Pharma Announces Exclusive License Agreement with Presage Biosciences for Voruciclib, An Oral, Selective CDK Inhibitor

Jun 15, 2017

Feinstein Institute Scientist Recognized for Innovative Chronic Lymphocytic Leukemia Research